Jack Y. Lee

982 total citations
17 papers, 762 citations indexed

About

Jack Y. Lee is a scholar working on Immunology, Immunology and Allergy and Oncology. According to data from OpenAlex, Jack Y. Lee has authored 17 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Immunology and Allergy and 5 papers in Oncology. Recurrent topics in Jack Y. Lee's work include Cell Adhesion Molecules Research (7 papers), Chemokine receptors and signaling (5 papers) and Immunotherapy and Immune Responses (3 papers). Jack Y. Lee is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Chemokine receptors and signaling (5 papers) and Immunotherapy and Immune Responses (3 papers). Jack Y. Lee collaborates with scholars based in United States and Saudi Arabia. Jack Y. Lee's co-authors include Robert Sackstein, Charles J. Dimitroff, Robert C. Fuhlbrigge, Shahin Rafii, Brenda M. Sandmaier, Tammy M. Martin, Michael P. Davey, David O. Zamora, Stephen R. Planck and James T. Rosenbaum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Jack Y. Lee

14 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Y. Lee United States 11 341 264 231 207 135 17 762
Karin Schweitzer Netherlands 9 205 0.6× 282 1.1× 184 0.8× 159 0.8× 102 0.8× 12 671
Elizabeth M. Morse United States 11 602 1.8× 416 1.6× 125 0.5× 525 2.5× 103 0.8× 14 1.2k
Gem S. Burgess United States 6 372 1.1× 411 1.6× 125 0.5× 144 0.7× 146 1.1× 6 959
Clotilde Billottet France 14 193 0.6× 408 1.5× 92 0.4× 268 1.3× 95 0.7× 21 823
Paula B. van Hennik Netherlands 18 243 0.7× 426 1.6× 67 0.3× 200 1.0× 167 1.2× 35 935
Andreas Enns Germany 9 137 0.4× 506 1.9× 122 0.5× 289 1.4× 66 0.5× 9 889
Maya Zigler United States 17 273 0.8× 565 2.1× 109 0.5× 300 1.4× 53 0.4× 23 961
Pamela N. Pharr United States 13 245 0.7× 335 1.3× 57 0.2× 161 0.8× 120 0.9× 22 739
Christine M. Labno United States 13 726 2.1× 381 1.4× 253 1.1× 148 0.7× 52 0.4× 15 1.2k
Javier Redondo-Muñóz Spain 16 225 0.7× 576 2.2× 90 0.4× 251 1.2× 234 1.7× 27 990

Countries citing papers authored by Jack Y. Lee

Since Specialization
Citations

This map shows the geographic impact of Jack Y. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Y. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Y. Lee more than expected).

Fields of papers citing papers by Jack Y. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Y. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Y. Lee. The network helps show where Jack Y. Lee may publish in the future.

Co-authorship network of co-authors of Jack Y. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Y. Lee. A scholar is included among the top collaborators of Jack Y. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Y. Lee. Jack Y. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lee, Jack Y., Bianca Nguyen, Anandaroop Mukhopadhyay, et al.. (2022). Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity. Molecular Therapy — Oncolytics. 25. 174–188. 10 indexed citations
2.
Lee, Jack Y., et al.. (2022). Abstract P006: Intratumoral electroporation of IL-12 and SARS-Cov-2 spike plasmids drives a coordinated vaccine response and elicits robust anti-tumor immunity. Cancer Immunology Research. 10(1_Supplement). P006–P006. 1 indexed citations
3.
Yokoyama, Yumi, Erin D. Lew, Ruth Seelige, et al.. (2019). Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor. Cancer Research. 79(8). 1996–2008. 70 indexed citations
4.
Merzaban, Jasmeen S., Jaime Imitola, Sarah C. Starossom, et al.. (2015). Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis. Glycobiology. 25(12). 1392–1409. 43 indexed citations
5.
Dauber, Andrew, Altan Ercan, Jack Y. Lee, et al.. (2014). Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. Human Molecular Genetics. 23(11). 2880–2887. 29 indexed citations
6.
Batal, Ibrahim, Jamil Azzi, Marwan Mounayar, et al.. (2014). The mechanisms of up-regulation of dendritic cell activity by oxidative stress. Journal of Leukocyte Biology. 96(2). 283–293. 29 indexed citations
7.
Lee, Jack Y., et al.. (2009). Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions. Journal of Leukocyte Biology. 86(6). 1285–1294. 20 indexed citations
8.
Ngo, Hai T., Xavier Leleu, Jack Y. Lee, et al.. (2008). SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood. 112(1). 150–158. 92 indexed citations
9.
Davey, Michael P., Tammy M. Martin, Stephen R. Planck, et al.. (2006). Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvascular Research. 71(2). 103–107. 52 indexed citations
10.
Lee, Jack Y.. (2002). On the Morgan-Voyce Polynomial Generalization of the First Kind. ˜The œFibonacci quarterly. 40(1). 59–65.
11.
Lee, Jack Y.. (2001). Some Basic Line-Sequential Properties of Polynomial Line-Sequences. ˜The œFibonacci quarterly. 39(3). 194–205. 2 indexed citations
12.
Dimitroff, Charles J., et al.. (2001). Differential L-Selectin Binding Activities of Human Hematopoietic Cell L-Selectin Ligands, HCELL and PSGL-1. Journal of Biological Chemistry. 276(50). 47623–47631. 50 indexed citations
13.
Dimitroff, Charles J., Jack Y. Lee, Shahin Rafii, Robert C. Fuhlbrigge, & Robert Sackstein. (2001). Cd44 Is a Major E-Selectin Ligand on Human Hematopoietic Progenitor Cells. The Journal of Cell Biology. 153(6). 1277–1286. 249 indexed citations
14.
Lee, Jack Y.. (2001). Some General Formulas Associated with the Second-Order Homogeneous Polynomial Line-Sequences. ˜The œFibonacci quarterly. 39(5). 419–429. 1 indexed citations
15.
Dimitroff, Charles J., Jack Y. Lee, Robert C. Fuhlbrigge, & Robert Sackstein. (2000). A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proceedings of the National Academy of Sciences. 97(25). 13841–13846. 110 indexed citations
16.
Lee, Jack Y.. (1997). On Some Basic Linear Properties of the Second-Order Inhomogeneous Line-Sequence. ˜The œFibonacci quarterly. 35(2). 111–121. 1 indexed citations
17.
Lee, Jack Y.. (1992). The Golden-Fibonacci Equivalence. ˜The œFibonacci quarterly. 30(3). 216–220. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026